title: Percutaneous Endoscopic Gastrostomy Tube in a Syncardia™ Total Artificial Heart.
abstract: As a bridge to transplant, the Syncardia™ total artificial heart (TAH) is an option for patients who are not candidates for left ventricular assist devices (LVAD) due to right ventricular failure. The need for nutritional support in these patients is essential for a favorable outcome. Low body mass indexes and albumin levels have been associated with increased morbidity and mortality in cardiac surgery patients [Alverdy 2003]. It is not uncommon for postoperative patients to have difficulty in consuming enough calories after surgery, which is further complicated by a hypermetabolic demand due to surgical stress. Enteral nutrition has typically been favored for gut mucosal integrity and bacterial flora [Alverdy 2003] [Engleman 1999]. We describe the need for prolonged enteral nutritional support in a TAH patient that was accomplished with a percutaneous endoscopic gastrostomy (PEG) tube.
authors.affiliation: Pennsylvania State University College of Medicine Department of Anesthesiology and Perioperative Medicine, Hershey, Pennsylvania, USA.
authors.forename: Amit
authors.initials: A
authors.lastname: Prasad
authors.affiliation: Pennsylvania State University College of Medicine Department of Anesthesiology and Perioperative Medicine, Hershey, Pennsylvania, USA.
authors.forename: Kai
authors.initials: K
authors.lastname: Singbartl
authors.affiliation: Pennsylvania State University College of Medicine Heart and Vascular Institute, Hershey, Pennsylvania, USA.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Boone
authors.affiliation: Pennsylvania State University College of Medicine Heart and Vascular Institute, Hershey, Pennsylvania, USA.
authors.forename: Behzad
authors.initials: B
authors.lastname: Soleimani
authors.affiliation: Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
authors.forename: Mohamad
authors.initials: M
authors.lastname: Zeriouh
authors.affiliation: INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma.
authors.forename: M
authors.initials: M
authors.lastname: Loebe
authors.affiliation: INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma.
authors.forename: Michael
authors.initials: M
authors.lastname: Koerner
authors.affiliation: Syncardia Systems Tuscon, Arizona, USA.
authors.forename: J Elisabeth
authors.initials: JE
authors.lastname: Oei
authors.affiliation: Pennsylvania State University College of Medicine Heart and Vascular Institute, Hershey, Pennsylvania, USA.
authors.forename: Christoph E
authors.initials: CE
authors.lastname: Brehm
authors.affiliation: Pennsylvania State University College of Medicine Heart and Vascular Institute, Hershey, Pennsylvania, USA.
authors.forename: Ali
authors.initials: A
authors.lastname: Ghodsizad
mesh_terms: D009202:Cardiomyopathies / Q000628:therapy*; D003131:Combined Modality Therapy / Q000295:instrumentation / Q000379:methods; D016099:Endoscopy, Gastrointestinal / Q000295:instrumentation* / Q000379:methods; D004750:Enteral Nutrition / Q000295:instrumentation* / Q000379:methods; D004867:Equipment Design; D005774:Gastrostomy / Q000295:instrumentation* / Q000379:methods; D006354:Heart, Artificial; D006801:Humans; D007441:Intubation, Gastrointestinal / Q000295:instrumentation* / Q000379:methods; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome